Soon two years will have passed since I became President of JSCC and I would like to thank you all for your continuing support.
Last December, Prof. Yukio Ando made the arrangements for the 56th Annual Meeting of the Japan Society of Clinical Chemistry to be held in Kumamoto. A major objective was to support reconstruction following the Kumamoto Earthquake that occurred last April. The meeting was very rich in academic, technical and educational content, and was very well attended. It was a great pleasure to see that the participants were so satisfied with the program. I am very grateful to Prof. Ando, Prof. Matsui, Dr. Ikeda, Dr. Shinriki, and the staff of Kumamoto University hospital for their contributions to the meeting’s success.
JSCC has contributed greatly to the standardization of clinical laboratory testing, which is being promoted on a global level by IFCC. Just before the Kumamoto meeting, the APFCB Congress had been held in Taiwan and during it, JSCC had organized a symposium on standardization and harmonization in Japan. There were also symposia on standardization and harmonization arranged by member organizations of IFCC and APFCB from various countries. I felt that the standardization and harmonization of clinical laboratory testing are now absolutely essential if we are to provide truly scientific medical care.
IFCC has various committees that are very active internationally and we continually recommend JSCC members for them. We see this as an opportunity to gain good ideas from other committee members and share ideas that work well in Japan with them.
A report on the project to change the ALP activity measurement method from the JSCC consensus method to the IFCC method has been prepared by Prof. Yamadate, and approved by JSCC directors. As the next step, we will collaborate with JCCLS, JACRI and other clinical laboratory-related societies in achieving a change to a method that meets the consensus of all. In this regard, JCCLS, JACRI and JSCC concluded a comprehensive collaborative contract last September with the assistance of the Judicial and Ethical Affairs Committee. This should guarantee transparency in the content of projects and accelerate their progress.
It is no exaggeration to say that clinical chemistry is fundamental to controlling the quality of laboratory results. In order to ensure that clinical chemistry provides accurate laboratory results for use in medical care, good quality control and management of individual data are essential. In this regard, we have already operated the “Certified Clinical Chemistry and Immunochemistry Quality Assurance Medical Technologist” qualification system together with JAMT, and the “Certified Clinical Chemistry and Immunochemistry Quality Assurance Professional” qualification system has just been inaugurated. The latest system is mainly for professionals working in R&D at educational institutions and companies. We hope that many professionals will be interested in these systems and take their certification examinations.
Last year, we established the Committee on Pitfall Research and its activities have been progressing smoothly. Those of the Publications Committee, Public Relations Committee, and Future Directions Committee are also going well. Membership is steadily increasing. I am convinced that this is the result of excellent cooperation among directors, committees and company members, and would like to express my appreciation to them all.
The major events of this year are our board meeting in March (for the change of directors that takes place every two years), the general meeting of JSCC members (Tokyo) in June, IFCC-EFLM EuroMedLab (Athens) in June, our annual meeting (Prof. Hitoshi Chiba, Sapporo) in October, and the IFCC WorldLab (Durban) in October. I hope that many professionals in the field will register for these events and submit papers, and look forward to meeting you all in Sapporo, at other meetings in Japan or those held in other countries.
Finally, I would like to inform you that I will continue my efforts to promote the realization of JSCC’s mission of “Developing Innovative Scientific Clinical Chemistry and Laboratory Medicine Techniques”
I would be very grateful for your continuing cooperation in these efforts.
Masato Maekawa, MD, PhD
President, Japan Society of Clinical Chemistry